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ABSTRACT 
Molecular oxygen and carbon dioxide are 
the primary substrate and product of oxidative 
metabolism, respectively. Hypoxia (low oxygen) 
and hypercapnia (high carbon dioxide) are co-
incidental features of the tissue microenvironment 
in a range of pathophysiologic states including 
acute and chronic respiratory diseases. The 
hypoxia inducible factor (HIF) is the master 
regulator of the transcriptional response to 
hypoxia, however little is known about the impact 
of hypercapnia on gene transcription. Because of 
the relationship between hypoxia and 
hypercapnia, we investigated the effect of 
hypercapnia on the HIF pathway.  Hypercapnia 
suppressed HIF-α protein stability and HIF target 
gene expression both in mice and in cultured cells 
in a manner that was at least in part independent 
of the canonical O2-dependent HIF degradation 
pathway. The suppressive effects of hypercapnia 
on HIF-α protein stability could be mimicked by 
reducing intracellular pH at constant pCO . 2
Bafilomycin A1, a specific inhibitor of vacuolar-
type H+-ATPase that blocks lysosomal 
degradation, prevented the hypercapnic 
suppression of HIF-α protein. Based on these 
results, we hypothesize that hypercapnia counter-
regulates activation of the HIF pathway by 
reducing intracellular pH and promoting 
lysosomal degradation of HIF-α subunits. 
Therefore, hypercapnia may play a key role in the 
pathophysiology of diseases where HIF is 
implicated. 
 
INTRODUCTION 
Current atmospheric CO2 levels are 
relatively low when compared with those 
recorded throughout the natural history of the 
planet (1). Not surprisingly, therefore, a range of 
organisms as diverse as bacteria, fungi, plants and 
mammals mount physiologic responses to 
hypercapnia (2). It is now clear that CO2, like 
other physiologic gases such as oxygen and nitric 
oxide, can be sensed by cells and can elicit 
adaptive transcriptional responses (2-4).  
As O2 consumption is coupled to CO2 
production, an intimate inverse relationship exists 
between levels of these gases in cells and tissues. 
Furthermore, O2 and CO2 levels may become 
perturbed during certain pathophysiologic states 
(3,5). Hypoxia and hypercapnia can co-occur in 
respiratory disorders such as obstructive sleep 
apnea syndrome, pneumonia and chronic 
obstructive pulmonary disease (6,7). In acute lung 
injury hypoxia may arise, while permissive 
hypercapnia is often tolerated as a protective 
ventilatory strategy in patients presenting with 
this disorder (8,9). Hypercapnia and hypoxia also 
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influence inflammatory processes (10-12). During 
inflammation, oxygen consumption is 
significantly elevated leading to tissue hypoxia; it 
is likely that this also has consequences for tissue 
CO2 levels (3,11). 
HIF (which comprises HIF-1,HIF-2 and 
HIF-3 isoforms) is the master transcriptional 
regulator of the cellular response to hypoxia (13). 
Canonical HIF degradation relies on the activity 
of O2-dependent prolyl hydroxylases (PHDs 1-3) 
(14). In normoxia, PHDs enzymatically modify 
HIF-α subunits on proline residues within the 
oxygen-dependent degradation domain (ODD; 
14). HIF-α is subsequently targeted for 
ubiquitination and proteasomal destruction, with 
this reaction being mediated by the von Hippel 
Lindau (pVHL) E3 ligase complex. The 
asparaginyl hydroxylase factor inhibiting HIF 
(FIH) confers a second mechanism of O2-
dependent repression by preventing HIF binding 
to CBP/p300. In hypoxia, when oxygen demand 
exceeds supply, the O2-dependent hydroxylases 
are no longer active; HIF-α stabilizes and 
translocates to the nucleus where it dimerizes with 
its constitutively-expressed β subunit. The HIF 
heterodimer binds to hypoxia response elements 
at or near promoters and enhancers of genes, 
where it promotes the formation of a 
transcriptional complex. HIF regulates the 
transcription of a host of targets, including those 
with angiogenic, vasodilatatory, inflammatory 
and glycolytic functions (13-14). Recently 
evidence has emerged for a separate O2-
independent, non-canonical HIF degradation 
pathway that is reliant on chaperone-mediated 
lysosomal autophagy (15-18). 
A number of previous publications that 
pre-date the discovery of HIF reported the 
suppression of the HIF-target erythropoietin 
(EPO) by hypercapnia, although the mechanism 
underpinning this suppression has not been 
established (19-24). In the current study, we 
examine the relationship between physiologically-
relevant levels of CO2, the HIF pathway and the 
HIF-target EPO. As hypoxia and hypercapnia 
often occur co-incidentally in disease, 
manipulation of HIF with CO2 might represent a 
novel window of opportunity in the treatment of 
conditions in which hypoxia is a constituent 
feature. 
 
EXPERIMENTAL PROCEDURES 
Animal model of hypercapnia – Two 
separate sets of in vivo experiments were 
performed. In each case, mice were administered 
an 8mg intra-peritoneal injection of the 
pharmacologic hypoxia mimetic, 
dimethyloxalylglycine (DMOG) or the equivalent 
saline vehicle control (25). Mice were then placed 
in hypercapnic conditions (10% CO2 / 21% O2) or 
in room air (0.04% CO2 / 21% O2) for 6 hours. 
Experiment A was performed at Northwestern 
University, using 9-11 week old male C57BL/6 
mice, which were sacrificed with Euthasol 
euthanizing solution. Experiment B was 
conducted at University of Colorado Denver, with 
18-20 week old female ODD-Luc mice 
maintained on an FVB background (26). These 
mice were anesthetized with isoflurane prior to 
sacrifice by exsanguination and cervical 
dislocation. Both sets of mice were sourced from 
The Jackson Laboratory (Bar Harbor, ME.) The in 
vivo studies were approved by the Institutional 
Animal Care and Use Committees at 
Northwestern University and the University of 
Colorado Denver as appropriate. The 
experimental set from which each figure 
originated is referred to in the associated figure 
legend. EPO values were determined with either 
Mesoscale Mouse/Rat Hypoxia Serum/Plasma Kit 
(Mesoscale Diagnostics, Rockville, MD) or  
Quantikine mouse EPO ELISA (R&D systems, 
Minneapolis, MN). To extract protein, mouse 
tissue was homogenised in RIPA buffer with the 
TissueLyzer II (Qiagen, Venlo, Netherlands.). 
The homogenized supernatant was subject to 3 
cycles of centrifugation (14,000 rpm x 10mins) 
and sonication.  
Cell culture – Human HEK 293 
embryonic kidney cells, A549 adenocarcinoma 
alveolar basal epithelial cells, HeLa cervical 
cancer cells, HCT 116 colorectal carcinomia cells 
as well as renal adenocarcinoma RCC4 and 786-O 
cells were all used for in vitro experiments. Cells 
were maintained according to ATCC 
recommendations (Manassas, VI.). Cells were 
incubated at 37°C in an atmosphere of 21% O2 
and 5% CO2 prior to experimental exposures. 
Hypercapnic and hypoxic exposure in 
vitro – Cells were exposed to defined atmospheric 
conditions in environmental chambers (Coy 
Laboratories, Grass Lake, MI.).  Experimental 
atmospheres were designed to mimic the levels of 
CO2 and O2 recorded in pathophysiologic 
conditions (27,28). Normocapnia was defined as 
5% CO2 that is equivalent to 35-37 mmHg 
(normal physiologic pCO2). Hypercapnia in vitro 
was defined as 7.5, 10, 15 or 20% CO2; these 
values are representative of CO2 levels 
encountered in disease that are equivalent to > 45 
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mmHg (physiological hypercapnia pCO2) (29). 
Normoxia was defined as 21% O2 whereas 
hypoxia was 1% O2. The levels of hypercapnia 
utilised did not significantly affect cell viability 
(data not shown). At the end of each experimental 
exposure, cell lysates were harvested within the 
chambers to prevent the confounding effects of 
re-oxygenation and CO2 desaturation.  
CO2 buffered media – Media was 
supplemented with either sodium bicarbonate or 
Tris base in order to obtain a pH of 7.4 at all CO2 
levels as described in previously published work 
(10,30).  Media was pre-equilibrated overnight in 
the experimental atmosphere. Media pH readings 
were taken at the beginning and end of each 
exposure to ensure uniformity between and within 
experiments as well as across the range of CO2 
concentrations.                     
Western blotting – Proteins were 
quantified with a Protein Assay kit (Bio-Rad, 
Hercules, CA) and subsequently resolved in 8-
15% poly-acrylamide gels. Separated proteins 
were then transferred to nitrocellulose membranes 
and incubated overnight in primary antibodies. 
The following primary antibodies were used: 
HIF-1α (610958) (1:500, Mouse) (BD 
Biosciences, San, Jose, CA); HIF-1α (MAB3582) 
(1:500, Mouse) (Milllipore, Ontario, Canada), 
HIF-2α (NB100-122) (1:1,000, Rabbit) (Novus, 
Littleton, CO), HIF-1β (NB100-982) (1:1,000, 
Rabbit) (Novus, Littleton, CO), Hydroxylated 
HIF-1α (D43B5) (1:1,000, Rabbit) (Cell 
Signalling Technology, Beverly, MA), β-actin 
(A5316) (1:10,000, Mouse) (Sigma Aldrich, St. 
Louis, MI) pVHL (2738) (1:1000, Rabbit) (Cell 
Signalling Technology, Beverly, MA) GFP 
(2555) (1:2,000, Rabbit) (Cell Signalling 
Technology, Beverly, MA) and carbonic 
anhydrase IX (H-120) (1:2,000, Rabbit) (Santa 
Cruz, Pasa Robles, CA). Secondary antibodies 
were applied (Cell Signalling Technology, 
Beverly, MA) and bands were detected using a 
chemiluminescence kit (Thermo Scientific, 
Waltham, MA). Densitometric values were 
obtained with ImageJ (National Institutes of 
Health, Bethedsa, MD).  
Intracellular pH assay – HEK 293 cells 
were loaded with 5µM BCECF-AM (Molecular 
Probes, Eugene, OR.) dissolved in Opti-MEM 1 
(Life Technologies, Carlsbad, CA) and left for 30 
mins at 5% CO2 / 95% air. The probe was then 
removed and cells were incubated in normocapnia 
(5% CO2) or hypercapnia (10% CO2) for 4 hours. 
At the end of this time, medium was removed and 
fluorescence was measured using a plate reader. 
The fluorophore was excited at 485nm (λ1) and 
444nm (λ2) and emission was recorded at 538nm 
in each case. BCECF intracellular fluorescence 
was determined by calculating the ratio of λ1/λ2.  
Media Mixes for pH buffering 
experiments: For the experiments outlined   in 
Figs. 4C-G, 4 media mixes were used to buffer 
extracellular pH. Dulbecco’s Modified Eagle’s 
Medium 1152 powder (Sigma Aldrich, St. Louis, 
MI) was re-suspended in water and supplemented 
with 10% fetal bovine serum and 
penicillin/streptomycin antibiotic mix. Defined 
amounts of sodium bicarbonate (NaHCO3) were 
added to the media to buffer extracellular pH. In 
order of increasing acidity the media contained 
the following mass and concentration of NaHCO3 
per 500mls: Mix 1: 2.21g, 52.6mM,; Mix 2: 
1.23g, 29.3mM; Mix 3: 0.48g, 11.43mM; Mix 4: 
0g, 0mM. Osmolarity was balanced using NaCl 
throughout. 
HIF luciferase reporter assay – HeLa 
cells were transfected with a firefly luciferase 
reporter under the control of a hypoxia response 
element (HRE) 24 hours before the start of an 
experimental exposure. In order to quantify 
luciferase activity, cells were lysed with reporter 
lysis buffer (Promega, Madison, WI). 
Luciferin/ATP substrate (Promega, Madison, WI) 
was then added to cell lysates, and the luciferase 
activity was quantified in a luminometer (Bio-
Rad, Hercules, CA). β-galactosidase under the 
control of an SV40 promoter was used as a 
transfection control in these experiments. All 
values were normalised to β-galactosidase before 
fold changes were calculated as previously 
described (31). 
Quantitative real time PCR – Primers 
(Eurofins MWG Operon, Ebersberg, Germany) 
were used to quantify levels of HIF-1α (Forward 
Primer –ACAAGTCACCACAGGAC- 
-AG) and HIF-2α (Forward Primer CAACCTGC-
-AGCCTCAGTGTATC) mRNA. PCR outputs 
were normalised to 18S rRNA and final values 
were calculated according to the ΔCt method. 
Statistical analyses: Data are summarised 
as mean ± SEM for n independent experiments. 
Statistical significance was assessed using a T-
test, a Mann-Whitney test or one-way ANOVA 
followed by the appropriate post-test. Within the 
figures, levels of statistical significance are 
denoted as *P≤0.05; **P ≤0.01; ***P≤0.001 
****P≤0.0001 and NS; non-significant. 
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RESULTS 
Hypercapnia suppresses the HIF pathway 
in vivo – EPO is a prototypic HIF-dependent 
gene. In a mouse model, we observed a 
suppressive effect of hypercapnia on serum EPO 
levels (Fig. 1A). This is consistent with previous 
studies examining the effect of hypercapnia on 
EPO expression and indicates the sensitivity of a 
well-characterised HIF target gene to hypercapnia 
(19-24). Since EPO is preferentially regulated by 
the HIF-2 isoform, we next investigated the 
impact of hypercapnia on HIF-2α protein (32). In 
order to activate the HIF response, mice were 
treated with the hydroxylase inhibitor DMOG 
prior to exposure to hypercapnia (10% CO2) or 
room air (0.04% CO2) for 6 hours. DMOG 
increased levels of HIF-2α protein in 
normocapnia in both brain and liver tissue (Fig. 
1B; data not shown for brain).  Hepatocytes are 
the main source of extrarenal EPO in adults (32). 
In the liver, we found that hypercapnia suppressed 
DMOG-induced HIF-2α protein stabilization (Fig. 
1B). Similar results were found in brain tissue 
(data not shown). While we were technically 
unable to consistently detect HIF-1α protein in 
tissues by immunoblot, we found that DMOG 
treatment stimulated expression of the HIF-1 
target gene, carbonic anhydrase IX, in a manner 
that was significantly blunted by hypercapnia 
(data not shown). In contrast, HIF-1β, a 
constitutively expressed stable subunit that is not 
subject to O2-dependent degradation, was not 
affected by either DMOG or hypercapnia (data 
not shown). Taken together, these data suggest 
that hypercapnia exerts a selectively suppressive 
effect on HIF-α protein isoforms and downstream 
genes in vivo.  
Hypercapnia suppresses the HIF pathway 
in vitro – Consistent with our observations in 
mice, both basal and DMOG-induced HIF-2α 
protein levels were suppressed by hypercapnia 
(10% CO2) in HEK 293 cells (Fig. 2A). 
Furthermore, we found that hypercapnia reduced 
DMOG-stabilized HIF-1α protein in HEK 293 
cells (Fig. 2B); these results were replicated in 
other epithelial and non-epithelial cell lines 
(A549, HCT 116, THP-1, and HeLa cells; data 
not shown).  Hypercapnia also decreased the 
hypoxic stabilization of HIF-1α protein in HEK 
293 and HeLa cells (data not shown). Moreover, 
hypercapnia suppressed DMOG-induced HIF-1α 
protein expression in HEK 293 cells at all degrees 
of hypercapnia tested (10%, 15% and 20% CO2) 
(Fig. 2C). An alternative hydroxylase inhibitor, 
JNJ1935, was also used to increase HIF protein 
levels (33). Hypercapnia decreased JNJ1935-
induced HIF-1α protein stabilization (Fig. 2D).  
To develop our understanding of the 
hypercapnic suppression of HIF, we attempted to 
titrate the level of CO2 required to destabilize HIF 
protein. HIF-1α protein levels induced by 
JNJ1935 were always suppressed by 10% CO2 but 
were more variable at 7.5% CO2 (Figs. 2D). This 
indicates a switch-like control mechanism where 
the hypercapnic suppression of HIF occurs above 
a level of 7.5% CO2. Consistent with our in vivo 
studies, HIF-1β protein levels were unaffected by 
changes in CO2 tension (Fig. 2E). Thus, 
hypercapnia suppresses labile elements of the HIF 
pathway (HIF-1α and HIF-2α protein) but not 
ubiquitously expressed stable subunits (HIF-1β 
protein) (34).  Next, a firefly luciferase reporter 
was used to measure the effect of CO2 on HIF-
dependent transcriptional activity. In agreement 
with the data reported above, hypercapnia 
suppressed HIF-dependent transactivation (Fig. 
2F). In summary, in vitro experiments support the 
observation that hypercapnia suppresses the HIF 
pathway. The suppression of HIF-1/2α protein by 
pathophysiologically relevant levels of CO2 was 
consistently recorded across multiple cell types.  
Hypercapnia does not affect canonical 
HIF degradation – To provide mechanistic 
insight into hypercapnic suppression of HIF 
signalling, we initially examined whether CO2 
modulates HIF-1/2α mRNA. Hypercapnia did not 
decrease mRNA for either gene (Figs. 3A and B). 
Therefore, hypercapnia likely exerts its 
suppressive influence on HIF-1/2α at a post-
transcriptional level. The major mechanism 
known to regulate HIF-α protein levels is the 
canonical O2-dependent HIF degradation pathway 
(35). Since CO2 is a product of the HIF 
hydroxylation reaction, we considered the 
possibility that HIF hydroxylation could be 
increased by hypercapnia. However the 
hydroxylated form of HIF-1α was suppressed 
rather than enhanced by elevated CO2 (Fig. 3C), 
suggesting that this is not the means by which 
hypercapnia destabilizes HIF protein. We also 
hypothesized that hypercapnia might increase 
proteasomal degradation of HIF. Nevertheless, in 
the presence of a proteasomal inhibitor, 
hypercapnia still suppressed both hydroxylated 
and total HIF-1α protein levels (Fig. 3C). Thus, 
hypercapnia does not induce proteasomal 
degradation of HIF.  
Given the fact that HIF-1/2α subunits 
both contain an O2-dependent degradation domain 
(ODD) (13) and both proteins are sensitive to 
 at U
ZH
 H
auptbibliothek / Zentralbibliothek Zuerich on A
ugust 26, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
Hypercapnia suppresses HIF 
5	  
	  
hypercapnia, we proposed that this region might 
also be responsive to CO2. To investigate this 
hypothesis, experiments were conducted with 
cells transfected with an ODD-GFP construct 
(36). We found that hypercapnia did not suppress 
the DMOG-induced expression of the ODD 
region of HIF (Fig. 3D). Therefore, the ODD 
confers O2 sensitivity, but this isolated HIF-1α 
domain is not suppressed by hypercapnia. The 
inability of hypercapnia to suppress the isolated 
ODD region further indicates that the effect of 
CO2 on HIF-α expression is likely independent of 
the canonical O2-dependent degradation pathway. 
In order to further test this important point, we 
next evaluated whether hypercapnia alters levels 
of pVHL protein, another key component of the 
canonical HIF degradation machinery. However, 
expression of pVHL remained unaffected by 
either hypercapnia or DMOG treatment (Fig. 3E). 
We subsequently examined whether a functional 
pVHL pathway is required for the hypercapnic 
suppression of HIF. To address this, we used two 
renal cell carcinoma cell lines that do not express 
functional pVHL and consequently display 
endogenous HIF protein stabilization. We found 
that hypercapnia suppressed DMOG-induced 
HIF-2α protein in 786-O cells and endogenous 
HIF-2α protein expression in RCC4 cells (Figs. 
3F & 3G). These results support the concept that 
pVHL is not required for the hypercapnic 
suppression of HIF. Together, these data 
demonstrate that the hypercapnic suppression of 
HIF does not occur via canonical O2-dependent 
pVHL/proteasome-mediated HIF degradation 
pathway.  
Hypercapnic suppression of HIF is 
mediated by lysosomal degradation – 
Hypercapnia causes cellular acidosis via the 
conversion of elevated CO2 and H20 into carbonic 
acid which rapidly disassociates into bicarbonate 
and H+ ions. Recently, an O2-independent 
mechanism of HIF protein degradation has been 
described involving lysosomes (15-18). As an 
acidic environment is optimal for lysosomal 
functioning, we focused on this particular non-
canonical HIF degradative pathway (37). 
Vacuolar H+-ATPases (V-ATPases) are 
ubiquitous proton pumps that are up-regulated at 
reduced pHi (38). To examine the role of 
lysosomal degradation in the hypercapnic 
suppression of HIF, we used bafilomycin A1 
(Baf-A1). Baf-A1 is a specific inhibitor of V-
ATPase and as such, prevents the V-ATPase-
mediated acidification of lysosomes thus reducing 
autophagic degradation (39). Incubation with Baf-
A1 increased both basal and DMOG-stabilized 
HIF-1α protein in normocapnia in a dose-
dependent manner (Fig. 4A). We subsequently 
investigated whether an increase in lysosomal 
degradation is responsible for the hypercapnic 
suppression of HIF. Interestingly Baf-A1 
treatment prevented the hypercapnia-induced 
decrease of HIF-1α protein (Fig. 4B). This 
suggests that the hypercapnic suppression of HIF-
1α protein is mediated at least in part by 
lysosomal degradation, and an acidic environment 
within the lysosome is required to mediate this 
effect.  
We next focused on evaluating whether 
the suppressive effects of hypercapnia on HIF-α 
protein could be re-capitulated by artificially 
reducing extracellular pH. Hypercapnia reduced 
intracellular pH compared to normocapnia, as 
measured by BCECF fluorescence (data not 
shown). Using media buffered with different 
amounts of sodium bicarbonate, we found that the 
stabilization of DMOG-induced HIF-1α and HIF-
2α protein was affected by the change in pHe and 
pHi (Figs. 4C and D; pHi data not shown). In 
normocapnia, decreasing pHi with more acidic 
extracellular media resulted in HIF-1α 
suppression (Fig. 4D). In hypercapnia, decreasing 
pHi with more acidic extracellular media also 
decreased HIF-1α and HIF-2α protein 
stabilization (Figs. 4C and D).  In contrast, HIF-
1β protein levels were unaffected by pHe and pHi 
(Fig. 4E). Similarly, hypoxia-induced HIF1/2α 
protein stabilization can also be suppressed by 
elevated CO2 or by decreasing pHe (Figs. 4F and 
G). These data demonstrate that HIF stabilization 
is sensitive to changes in pH comparable to those 
experienced during hypercapnia. Taken together, 
these results demonstrate that it is possible to 
mimic the suppressive effect of hypercapnia on 
HIF-α protein by reducing pHi.  
Based on these data, we hypothesize that 
the hypercapnic suppression of HIF is due to non-
canonical O2-independent lysosomal degradation 
of HIF-α protein. Pharmacological inhibition of 
lysosomal activity can prevent hypercapnia-
dependent degradation of HIF-α. Both 
hypercapnia exposure and exogenously reducing 
pH can destabilize HIF-α. The extent to which 
hypercapnia, per se, or the change in media pH 
associated with hypercapnic acidosis are 
responsible for HIF-α degradation is not yet fully 
elucidated.  
DISCUSSION 
Hypoxia and hypercapnia are often 
concurrent microenvironmental features at a 
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cellular level and can also co-incidentally occur in 
disease (3,5,6). Yet despite the close association 
between these gases, the impact of CO2 on 
cellular responses to low O2 remain poorly 
understood. Here we provide evidence of 
suppression of the hypoxic response by 
hypercapnia, as a counter-regulatory mechanism 
reducing the activation of the HIF pathway. Using 
an animal model of hypercapnia, we demonstrated 
that the HIF-2 target, EPO, is suppressed by high 
CO2. Hypercapnia also impaired the accumulation 
of HIF-2α protein in vivo in the presence of the 
hypoxia mimetic, DMOG. Hypercapnic 
suppression of HIF-1/2α protein was recorded in 
several cell lines of diverse origin. Furthermore, 
HIF-dependent transcriptional activity was 
diminished by hypercapnia. Lysosomal inhibition, 
using Baf-A1, prevented the hypercapnic 
suppression of HIF-1α protein. In our in vitro 
model, pHi was decreased by high CO2, and we 
found that artificially decreasing pHe and pHi 
destabilized HIF-1/2α protein in normocapnia and 
hypercapnia. Thus, we propose that the low pHi 
conditions present in hypercapnia may facilitate 
lysosomal degradation of HIF-α protein.  
The degradation of HIF protein by non-
canonical, O2-independent lysosomal chaperone-
mediated autophagy (CMA) is becoming 
increasingly appreciated (15-18,40-42). HIF-1α is 
targeted for lysosomal degradation via a specific 
non-canonical KFERQ-like CMA pentapeptide at 
positions 529-533 (NEFKL) in the ODD (17). We 
analysed HIF-2α according to the criteria for 
identifiying KFERQ-like motifs (43) and found a 
similar CMA sequence at positions 494-497 
(NDLKI). Although in our experiments the 
isolated ODD region was not suppressed by 
hypercapnia, it is possible that the full HIF-1α 
protein sequence is needed to facilitate the 
interaction between HIF-1α and the mediators of 
lysosomal degradation. The chaperone protein 
HSPA8 and the lysosome membrane receptor 
LAMP2A have been implicated in the lysosomal 
degradation of HIF-1α (17). This process is also 
contingent upon K63-linked ubiquitination of 
HIF-1α by the ubiquitin E3 ligase STUB1 (18). 
Lysosomal degradation of HIF-1α is activated by 
nutrient deprivation, and in livers extracted from 
starved animals, the localization of HIF-1α in 
lysosomes is increased (17,18).  In the context of 
our results, the acidic pH conditions extant in 
hypercapnia may deprive cells nutritionally, 
which respond to this challenge by lysosomally 
degrading HIF-α protein. Although we report an 
association between hypercapnia and selective 
lysosomal degradation of HIF-α protein, elevated 
CO2 has recently been demonstrated to inhibit 
macroautophagy in macrophages (44).  
A number of publications that predate the 
discovery of HIF document the hypercapnic 
suppression of EPO levels (19-24). Our study 
implicates the CO2-mediated reduction of EPO as 
being attributable to hypercapnic suppression of 
the HIF pathway. Previous papers theorized that 
hypercapnic repression of EPO is due to increased 
pulmonary ventilation and subsequent re-
oxygenation at sites of EPO synthesis (19-24). 
However Gates et al. recorded only a modest 
increase in arterial blood gas oxygenation upon 
exposure for 2 days (12). The results of our 
animal studies are concordant with our in vitro 
data despite the fact that cells are not subject to 
re-oxygenation. Given this evidence, we can infer 
that the CO2-mediated reduction in EPO is likely 
due at least in part to HIF suppression, rather than 
the effects of systemic re-oxygenation. Recent 
works that have demonstrated the ability of 100% 
CO2 to suppress hypoxic responses in tumours are 
supportive of our findings (45-48). Compared 
with room air controls, 100% CO2 was found to 
reduce HIF-1α stabilization and VEGF mRNA 
expression in mice implanted with a malignant 
human histiocytoma. 100% CO2 also decreased 
tumour growth while augmenting the 
effectiveness of chemotherapeutic doxorubicin 
treatment (45-48).  Suppression of the HIF 
pathway by hypercapnia is of clinical significance 
given the occurrence of hypoxia and its sequelae 
in numerous diseases. Depending on the cause of 
the constitutive hypoxia, it may be favourable to 
either activate or suppress HIF (35). During 
inflammation and colitis, HIF exerts a protective 
effect (11, 49,50).   In contrast, in cancer, 
intratumoral hypoxia and genetic mutations result 
in the up-regulation of HIF-1α, and the activation 
of HIF can promote tumorigenesis (35). Renal 
cell carcinoma are prone to generate pVHL-
deficient mutations, and as a result, HIF becomes 
endogenously stabilized, worsening prognosis 
(51). In pVHL-negative RCC tumours, we can 
speculate that hypercapnia could be utilised as a 
means of decreasing HIF stabilization beyond the 
pVHL-dependent canonical HIF degradation 
pathway. Conversely, the impact of modulating 
CO2 tension should also be investigated in 
disorders where HIF promotes recovery.  
In the future, the relationship between O2 
and CO2 levels in conditions such as 
inflammation and cancer should be tested 
experimentally. Interestingly, immune cells 
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extracted from patients with chronic obstructive 
pulmonary disease have a three-fold decreased 
stabilization of HIF-1α in response to hypoxic 
exposure for 24 hours compared to healthy 
individuals. However, the contribution of 
hypercapnia to this defective HIF response has 
not yet been examined (52). Further studies are 
warranted to assess direct associations between 
the levels of CO2, lysosomal degradation and 
those of HIF protein in vivo and would support 
the pathobiological relevance of our findings. The 
potential for hypercapnic acidosis to induce 
structural changes and subsequent denaturation of 
HIF-α subunits also needs to be tested 
experimentally (53).  
Thus, the repertoire of biological 
processes impacted by CO2 continues to grow (2). 
In this vein, our study demonstrates the ability of 
physiologically relevant levels of CO2 to counter-
regulate HIF activation. CO2 consistently 
suppresses both HIF-α protein and HIF-dependent 
targets in vivo and in vitro. Hypercapnia appears 
to exert these suppressive effects at least in part 
by reducing pHi, which facilitates non-canonical 
lysosomal degradation of HIF-α protein. It is 
likely that in pathophysiologies where high CO2 
exists, the hypercapnic suppression of the HIF 
pathway is an important feature of the disease 
microenvironment. The inhibition of the adaptive 
hypoxic response by CO2 represents a novel 
therapeutic option in diseases in which the HIF 
pathway is implicated. 
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FIGURE LEGENDS 
 
Figure 1: Hypercapnia suppresses the HIF pathway in vivo. 
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A: Circulating serum EPO levels in mice exposed to room air (0.04% CO2; 21% O2) or hypercapnia 
(10% CO2; 21% O2) for 6 hours. Data is presented as percentage EPO change relative to normocapnic 
mice (n=7 for all groups except 0.04% CO2/DMOG, which is n=6). Statistical significance was 
determined by t-test. B: Representative Western blot and quantitative densitometric analysis for liver 
HIF-2α protein normalised to liver β-actin (n=6) in mice treated with DMOG in the presence and 
absense of hypercapnia. Statistical comparison was made using by one-way ANOVA with Tukey’s 
post-test where ***P≤0.001 and **P≤0.01 for the comparisons indicated by brackets. All data are 
presented as mean ± SEM. The Western blot images displayed above originate from contiguous gels; 
samples were run in a different order to the way they are presented above, as indicated by the white 
space. Figure 1A represents data from both Experiment A and Experiment B mice while Figure 1B 
represents data from Experiment A mice.  
 
Figure 2: Hypercapnia suppresses the HIF pathway in vitro. 
A: Representative HEK 293 whole cell lysate HIF-2α protein immunoblots and densitometry 
normalised to β-actin from cells treated with or without DMOG (1mM) and exposed to normocapnia 
or hypercapnia for 4 hours. (n=6)  B: Representative HEK 293 HIF-1α protein immunoblots and 
densitometry normalised to β-actin from cells treated with or without DMOG (1mM) and exposed to 
normocapnia or hypercapnia for 4 hours. (n=3). C: HIF-1α and β-actin immunoblot from HEK 293 
whole cell lysates from cells treated with DMOG (1mM) or DMSO vehicle control and incubated for 
4 hours in normocapnia (5% CO2) or various degrees of hypercapnia (10%, 15% and 20% CO2) (n=3). 
D: HIF-1α and β-actin protein immunoblots from HEK 293 whole cell lysates from cells treated with 
JNJ1935 (100µM) or DMSO vehicle control and placed in either normocapnia (5% CO2) or 
hypercapnia (7.5% CO2 or 10% CO2) for 4 hours (n=3).  E: HIF-1β normalised to β-actin in HEK 293 
whole cell lysates from cells treated with DMOG (1mM) or DMSO vehicle control and incubated in 
normocapnia (5% CO2) or hypercapnia (10% CO2) for 4 hours (n=4). F: A hypoxia response element 
driven Firefly luciferase construct was used to measure the impact of CO2 tension on the activity of 
HIF-dependent transcriptional activity in HeLa cells. Cells were treated with DMOG (1mM) or 
DMSO vehicle control and exposed to normocapnia (5% CO2) or hypercapnia (10% CO2) for 24 
hours. β-galactosidase was used as a transfection control and all values were normalised to β-
galactosidase. Fold changes were calculated relative to normocapnic DMSO-treated samples at 24 
hours (n=4). All data are represented as mean ± SEM. Statistical significance was determined by one-
way ANOVA with Tukey’s post-test where *P≤0.05, **P ≤0.01 ***P ≤0.001 and NS; non-significant 
for the comparisons indicated by brackets. 
 
Figure 3: Hypercapnia does not affect canonical HIF degradation. 
A: Quantitative real-time PCR for HIF-1α mRNA from HEK 293 cells exposed to normocapnia (5% 
CO2) or hypercapnia (10% CO2) for 4 hours (n=3). B: Quantitative real-time PCR for HIF-2α mRNA 
from HEK 293 cells exposed to normocapnia (5% CO2) or hypercapnia (10% CO2) for 4 hours (n=3). 
C: Representative immunoblots of HIF-1α, hydroxylated HIF-1α and β-actin protein from HEK 293 
whole cell lysates  derived from cells incubated in normocapnia (5% CO2) or hypercapnia (10% CO2) 
for 4 hours with DMOG (1mM) or DMSO vehicle control as well as MG132 (10µM) (n=3). 
Densitometry is provided for hydroxylated HIF-1α normalised to β-actin. D: Representative 
immunoblot and densitometry for ODD-GFP and β-actin in HCT 116 cell whole cell lysates. Cells 
stably transfected with an ODD-GFP construct were exposed to normocapnia (5% CO2) or  
hypercapnia (10% CO2) for 4 hours with DMOG (1mM) or DMSO vehicle control (n=4).  E: 
Representative Western blot of von Hippel Lindau and β-actin protein in HEK 293 whole cell lysates 
from cells exposed to normocapnia (5% CO2) or hypercapnia (10% CO2) for 4 hours with DMOG 
(1mM) or DMSO vehicle control (n=3). F: Representative Western blot and densitometry for HIF-2α 
relative to β-actin extracted from RCC 786-O whole cell lysates extracted from cells incubated in 
normocapnia (5% CO2) or hypercapnia (10% CO2) with DMOG (1mM) or DMSO vehicle control for 
4 hours (n=3). G: Representative Western blot and densitometry for HIF-2α relative to β-actin in 
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RCC4 whole cell lysates from cells exposed to normocapnia (5% CO2) or hypercapnia (20% CO2) for 
8 hours (n=4). Data are represented as mean ± SEM. Statistical significance was determined by one-
way ANOVA with Tukey’s post-test where *P≤0.05 and ***P ≤0.001 for the comparisons indicated 
by brackets. The Western blot images displayed above all originate from contiguous gels; the samples 
in C were run on the same gel in a different order to the way in which they are presented above, as 
indicated by the white space.  
 
Figure 4: Hypercapnic suppression of HIF is mediated by lysosomal degradation. 
A: Western blot and densitometry for HIF-1α and β-actin in HEK 293 whole cell lysates derived from 
cells exposed to normocapnia (5% CO2) for 4 hours after treatment with DMOG (1mM), bafilomycin 
A1 (125nM and 250nM) or DMSO vehicle control (n=4). B: Representative Western blot and 
densitometry for HIF-1α and β-actin protein in HEK 293 whole cell lysates deived from cells after 
exposure to normocapnia (5% CO2) or hypercapnia (10% CO2) for 4 hours after application of 
DMOG (1mM), bafilomycin A1 (125nM) or DMSO vehicle control as indicated (n=4). In 4A and 4B 
the data (not normally distributed) were analyzed by Mann-Whitney test for the comparisons 
indicated by the brackets where *P≤0.05 and N.S.; non-significant. C-E: Media mixes were buffered 
with different quantities of sodium bicarbonate in order to alter extracellular pH (pHe). HEK 293 cells 
were incubated for 4 hours in normocapnia (5% CO2) or hypercapnia (10% CO2) with DMOG (1mM) 
or DMSO vehicle control with these media mixes. pHe values are displayed alongside the figures. 
These samples were measured for levels of C: HIF-1α protein and membranes were subsequently re-
blotted for D: HIF-2α and E: HIF-1β protein. Representative immunoblots and quantitative 
densitometry for each of these proteins normalised to β-actin are shown (n=3). F and G: Media mixes 
were buffered with different quantities of sodium bicarbonate in order to alter extracellular pH (pHe). 
HEK 293 cells were incubated for 24 hours in normoxic normocapnia (21% O2; 5% CO2), hypoxic 
normocapnia (1% O2; 5% CO2) or hypoxic hypercapnia (1% O2; 10% CO2) with these media mixes. 
pHe values are displayed alongside the figures. Levels of F: HIF-1α and G: HIF-2α protein were 
assessed by Western blot. Representative immunoblots and quantitative densitometry for each of these 
proteins normalised to β-actin are shown (n=3). Data are represented as mean ± SEM. The Western 
blot images displayed above all originate from contiguous gels; the samples in B were run on the 
same gel in a different order to the way in which they are presented above, as indicated by the white 
space. 
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FIGURE 1 
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FIGURE 2 
 
 
 
 
 
 
 
 
 
 
 at U
ZH
 H
auptbibliothek / Zentralbibliothek Zuerich on A
ugust 26, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
Hypercapnia suppresses HIF 
15	  
	  
FIGURE 3        
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FIGURE 4 
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